Journal of Rare Cardiovascular Diseases
ISSN: 2299-3711 (Print)
e-ISSN: 2300-5505 (Online)
Menu
Cardiac Amyloidosis in 2023: Transformative Advances in Diagnosis and Therapy
Leo Oscar
George Arthur
k. Amelia
Show More
1
University of Kentucky College of Medicine
Received: 2022-12-19
Revised: 2023-01-15
Accepted: 2023-03-18
Published: 2023-04-14
Full Text
Abstract
Cardiac amyloidosis, characterized by amyloid fibril deposition in the myocardium, has seen significant advancements in diagnosis and treatment over the past two decades. This paper reviews the current understanding of cardiac amyloidosis, emphasizing developments up to 2023, including novel diagnostic modalities, therapeutic strategies, and future research directions.
Keywords
Cardiac amyloidosis, amyloid fibril deposition, myocardium, diagnosis, treatment, advancements, 2023,
diagnostic modalities, therapeutic strategies, future research directions
Journal Help
Indexation
User
Keywords
Classification of Rare Cardiovascular Diseases
anticoagulation
atrial fibrillation
atrial septal defect
cardiomyopathy
computed tomography
congenital heart disease
echocardiography
electrocardiogram
electrocardiography
heart failure
implantable cardioverter‑defibrillator
magnetic resonance imaging
pregnancy
pulmonary arterial hypertension
pulmonary hypertension
rare cardiovascular disease
rare disease
right heart catheterization
right ventricular failure
Instruction for authors
Submit an article